The medicine check
Check the exact medicine
Get the full product name
For a medicine proposal, get its name and ask which condition it is intended to treat. Do this before comparing prices.
- Finished medicineAsk about its approved use
- Made to orderAsk why that change is needed
- Label says “for research”Ask what those words mean
Treat “peptide” as the beginning of the check
Tiny chemical parts linked into a short chain form a peptide.
Insulin is a peptide; some medicines used for weight loss are peptides too.
Under US rules checked as of September 26, 2026, the word “peptide” by itself does not show whether a product is allowed.
The rules depend on whether the exact product has Food and Drug Administration (FDA) approval, is made to order within the law, or is an unapproved medicine.
Ask why this specific product is being proposed for you. Keep a product’s name separate from a broad label for the care.
Ask about an approved product’s use
The FDA approved semaglutide (Ozempic) injections for blood sugar control in adults with type 2 diabetes, alongside diet and exercise, as of September 26, 2026.
Semaglutide (Wegovy) shots or tablets have FDA approval to help people lose weight and keep it off, alongside changes to food and activity, as of September 26, 2026.
Find out if the proposed use appears on its FDA label—the official product information—or is a different use. Ask for an explanation of that difference.
These are examples of approved uses, not the full list. Ask the doctor to show the use that applies to your problem.
Read the FDA product information
Write down whether the product is a shot or a pill, and what it is meant to treat.
Ask why medicine made to order is needed
Compounding means making medicine to order instead of supplying a finished product from a factory.
Even if a licensed pharmacy makes a compounded medicine, it has no FDA approval, as of September 26, 2026.
According to the FDA, compounding may meet a need an approved medicine cannot meet, or help when that medicine is unavailable, as of September 26, 2026.
Read the FDA compounding note
Ask who will make it and which state board holds that pharmacy’s licence.
Pause if the label says “for research”
For the peptide BPC-157, FDA records showed no product approved in the US, as of September 26, 2026.
Federal law does not allow retatrutide or cagrilintide to be compounded, the FDA also says, as of September 26, 2026.
A warning from the FDA covers unapproved weight medicines sold for people despite labels saying “not for human consumption” or “for research purposes,” as of September 26, 2026.
The words “not for human consumption” mean the product is not meant for people to take.
According to the FDA, these products have unknown quality and may harm people, as of September 26, 2026.
Read the FDA note on research products
Keep the exact name and label wording in your notes. Ask for the product’s approval record and why it is being offered.